We have been receiving a LOT of media attention about Obecalp. Thanks.

Your support has been tremendous!

We applaud people from around the world who have the desire to express their opinion about Obecalp. We appreciate opinions, but appreciate peer reviewed papers published in reputable medical journals even more. We thank you for your positive stories about us and we are doing our best to respond to each question or concern on an individual basis. Due to the overwhelming response, it might take awhile to get back to you, but rest assured, we will respond.

Rather than express our opinions which might be looked upon as medical advice (we don’t give medical advice) we have found some peer reviewed papers and US Government information that we felt useful in our development and sales of Obecalp as the “first standardized, pharmaceutical grade placebo for sale on the Internet and at retail stores.”

Here is an extract from the email we send along to prospective media personnel prior to our interviews. Some of the information makes into our story. Sadly, a lot of necessary information hits the cutting room floor. Normally the references which are not included are the most important to us and our customers.

Please remember that we do not give any medical advice. Obecalp is only a sugar tablet. It cannot treat or cure any type of illness. Anything we report is just a reference to information that we found and is readily available to anyone.

“Please review the following links prior to our interview. They were instrumental in the development of Obecalp. Number 4 is THE definitive and accepted answer (not just an opinion) about the ethical use of placebo. We could not have moved forward without number 4.

1. Columbia University study about the placebo effect.

2. Chicago study where close to half the ethical doctors claim to have given their patients a placebo.

3. Cough medicine for children as effective as placebo. Removed due to associated deaths.

4. “The ethics of the placebo in clinical practice” peer reviewed and published by the BMJ‘s Journal of Medical Ethics (link from our site)“Here

5. The NIH elicited researchers to study the ethical use of placebo in clinical practice. “The proposed initiative is expected to stimulate investigator-initiated research investigations on how placebos and placebo effects impact on clinical practice. An important goal is to understand what factors are necessary to elicit a placebo effect in clinical practice so that the benefits of the therapeutic “intervention can be enhanced to improve health and promote wellness.” The entire document may be found here.

6. Other references to ethical placebo use.

Thanks.
Efficacy Brands

Thanks a million for the terrific support we have received from both our customers and the press.

After your numerous requests, we will indeed be reformulating Obecalp and now offering a total of 8 different variations of our placebo.

Feel free to email us at any time.

To our potential distributors, please contact us and we will get product out to you. – DB